CG Invites Co

CG Invites Co ROCE

The Return on Capital Employed (ROCE) of CG Invites Co (083790.KQ) as of Oct 28, 2026 is -21.99 %. In the previous year, Return on Capital Employed (ROCE) was -55.80 % — a change of -60.58% (higher).

ROCE

-21.99 %

YoY

-60.58%

Last updated:

In 2025, CG Invites Co's return on capital employed (ROCE) was -21.99 %, a -60.58% increase from the -55.80 % ROCE in the previous year.

The CG Invites Co ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
0.56 KRW
Jan 1, 2019
-11.29 KRW
Jan 1, 2020
3.69 KRW
Jan 1, 2021
-11.69 KRW
Jan 1, 2022
-12.97 KRW
Jan 1, 2023
-11.00 KRW
Jan 1, 2024
-55.80 KRW
Jan 1, 2025
-21.99 KRW
The CG Invites Co ROCE history
YEARROCEYoY
-21.99 %-60.58%
-55.80 %+407.30%
-11.00 %-15.21%
-12.97 %+11.00%
-11.69 %-416.98%
3.69 %-132.67%
-11.29 %-2,125.57%
0.56 %-107.60%
-7.33 %+49.10%
-4.91 %-11.41%
-5.55 %-57.76%
-13.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG Invites Co Stock analysis

What does CG Invites Co do? CrystalGenomics, Inc. generates revenue through its Finished Pharmaceuticals Manufacturing segment, which produces and sells finished pharmaceuticals. The Pharmaceutical R&D Division provides clinical trial analysis and technical services while also selling new drugs. The company also operates in the real estate leasing business under the segment structure. The Others segment manufactures and sells hot fats and other household items. Revenue streams are derived from pharmaceutical manufacturing, R&D services, real estate leasing, and household product sales. The primary buyers for finished pharmaceuticals include healthcare providers and distributors. Clinical trial analysis and new drug sales target pharmaceutical companies and research institutions. Real estate leasing serves commercial tenants, while hot fats and household items are sold to retail consumers. The company's segments collectively serve diverse markets across healthcare, real estate, and consumer goods. CrystalGenomics, Inc. focuses on therapeutic discovery and development, with its R&D Division driving innovation in new drug sales. The Finished Pharmaceuticals Manufacturing segment ensures steady supply of established products. Real estate leasing and household item sales provide additional revenue streams. The company's business model integrates pharmaceutical production, research, and non-pharmaceutical ventures. CG Invites Co is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling CG Invites Co's Return on Capital Employed (ROCE)

CG Invites Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing CG Invites Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

CG Invites Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in CG Invites Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about CG Invites Co stock

Return on Capital Employed (ROCE) of CG Invites Co is -21.99 % in 2025.

Return on Capital Employed (ROCE) of CG Invites Co changed from -55.80 % to -21.99 %, representing a -60.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) CG Invites Co since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s CG Invites Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CG Invites Co

All Key Metrics — CG Invites Co